Trials / Completed

CompletedNCT02684045

Retrospective Chart Review to Assess Outcomes in Subjects That Received MAGNIFUSE® in the Posterolateral Lumbar Spine

A Retrospective Review of Charts to Assess Outcomes in Subjects That Received MAGNIFUSE® DBM in the Posterolateral Lumbar Spine

Status: Completed
Phase: —
Study type: Observational
Enrollment: 76 (actual)

Sponsor: Medtronic Spinal and Biologics · Industry
Sex: All
Age: —
Healthy volunteers: Not accepted

Summary

The purpose of this chart review is to assess outcomes in subjects that received MAGNIFUSE in the posterolateral lumbar spine at 1 or 2 continuous levels from L1-S1.

Conditions

Subjects Received MAGNIFUSE in Posterolateral Lumbar Spine

Timeline

Start date: 2017-03-01
Primary completion: 2017-08-15
Completion: 2017-08-15
First posted: 2016-02-17
Last updated: 2017-08-21

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02684045. Inclusion in this directory is not an endorsement.